Metastatic Rhabdoid Meningioma with BRAF V600E Mutation and Good Response to Personalized Therapy: Case Report and Review of the Literature

被引：25

作者：

Mordechai, Oz ^{[1
]}

Postovsky, Sergey ^{[1
,2
]}

Vlodavsky, Eugene ^{[2
,3
]}

Eran, Ayelet ^{[4
]}

Constantini, Shlomi ^{[5
]}

Dotan, Eynat ^{[6
]}

Cagnano, Emmanuela ^{[7
]}

Weyl-Ben-Arush, Myriam ^{[1
,2
]}

机构：

[1] Rambam Hlth Care Campus, Dept Pediat Hematol Oncol, IL-31096 Haifa, Israel

[2] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel

[3] Rambam Hlth Care Campus, Inst Pathol, IL-31096 Haifa, Israel

[4] Rambam Hlth Care Campus, Dept Radiol, IL-31096 Haifa, Israel

[5] Sourasky Med Ctr, Pediat Neurosurg Unit, Tel Aviv, Israel

[6] Sourasky Med Ctr, Dept Oncol, Tel Aviv, Israel

[7] Sourasky Med Ctr, Dept Pathol, Tel Aviv, Israel

来源：

PEDIATRIC HEMATOLOGY AND ONCOLOGY | 2015年 / 32卷 / 03期

关键词：

BRAF mutation; MEK inhibitor; meningioma; targeted therapy; MELANOMA; INACTIVATION; INHIBITION; DABRAFENIB; TRIAL;

D O I：

10.3109/08880018.2014.936058

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Rhabdoid meningioma is an aggressive phenotype of meningioma, associated with a poor prognosis. We present a very rare case of high-grade meningioma with rhabdoid features that eventually expressed in a coma state. Comprehensive genomic profiling using a Next Generation Sequencing (NGS) assay revealed three genomic alterations: activating BRAF mutation (V600E), loss of CDKN2A/2B, and APCI1307K. After treatment with BRAF inhibitor (dabrafenib), the child's clinical condition improved progressively. After seven months, an MEK inhibitor was added (trametinib).

引用

页码：207 / 211

页数：5

共 50 条

[1] METASTATIC RHABDOID PAPILLARY MENINGIOMA WITH BRAF V600E MUTATION AND GOOD RESPONSE TO PERSONALIZED THERAPY
Mordechai, O. Z.
Postovsky, S.
Vlodavsky, E.
Eran, A.
Constantini, S.
Cagnano, E.
Ben Arush, M.
PEDIATRIC BLOOD & CANCER, 2014, 61 : S186 - S186
[2] Gliosarcomas with the BRAF V600E mutation: a report of two cases and review of the literature
Wang, Leiming
Sun, Jian
Li, Zhuo
Chen, Li
Fu, Yongjuan
Zhao, Lihong
Liu, Li
Wei, Yukui
Teng, Lianghong
Lu, Dehong
JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (12) : 1079 - 1083
[3] Spinal cord anaplastic astrocytoma with BRAF V600E mutation: A case report and review of literature
Takamiya, Soichiro
Hatanaka, Kanako C.
Ishi, Yukitomo
Seki, Toshitaka
Yamaguchi, Shigeru
NEUROPATHOLOGY, 2020, 40 (03) : 275 - 279
[4] RECURRENT GANGLIOGLIOMA WITH BRAF V600E MUTATION RESPONSE TO VEMURAFENIB: CASE REPORT
Aguilera, Dolly
Mazewski, Claire
Janss, Anna
Castellino, Robert Craig
Schniederjan, Matthew
Hayes, Laura
Brahma, Barun
MacDonald, Tobey
NEURO-ONCOLOGY, 2014, 16 : 61 - 61
[5] Breast metastasis from rectal cancer with BRAF V600E mutation: a case report with a review of the literature
Hiroko Hasegawa
Yoko Nagata
Yuko Sakakibara
Masakazu Miyake
Kiyoshi Mori
Norikazu Masuda
Masayuki Mano
Shoichi Nakazuru
Hisashi Ishida
Eiji Mita
Clinical Journal of Gastroenterology, 2020, 13 : 153 - 157
[6] Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review
Fan, Yuqian
Yu, Jingjing
Zhao, Ming
FRONTIERS IN ONCOLOGY, 2022, 12
[7] Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation
Zaina T. Al-Salama
Drugs, 2021, 81 : 849 - 856
[8] BRAF V600E Mutation in Triple-Negative Breast Cancer: A Case Report and Literature Review
Wang, Liye
Lu, Qianyi
Jiang, Kuikui
Hong, Ruoxi
Wang, Shusen
Xu, Fei
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (1-2) : 54 - 60
[9] Breast metastasis from rectal cancer with BRAF V600E mutation: a case report with a review of the literature
Hasegawa, Hiroko
Nagata, Yoko
Sakakibara, Yuko
Miyake, Masakazu
Mori, Kiyoshi
Masuda, Norikazu
Mano, Masayuki
Nakazuru, Shoichi
Ishida, Hisashi
Mita, Eiji
CLINICAL JOURNAL OF GASTROENTEROLOGY, 2020, 13 (02) : 153 - 157
[10] Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation
Al-Salama, Zaina T.
DRUGS, 2021, 81 (07) : 849 - 856

← 1 2 3 4 5 →